Luca Benatti - Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
QNCX on Nasdaq
All Insider Reports
All Insider Reports

Luca Benatti - trading volume in the past year for Quince Therapeutics, Inc.

Holdings reported by Luca Benatti for Quince Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 39,179 $135,951 $3.47 26 Dec 2025 Direct
Director Stock Option (Right to Buy) 27,000 04 Jun 2025 Direct Common Stock

Transactions reported by Luca Benatti for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.